Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?

Detalles Bibliográficos
Autores principales: Derkay, Craig S., Wikner, Emily E., Pransky, Seth, Best, Simon R., Zur, Karen, Sidell, Douglas R., Klein, Adam, Rosen, Clark, Dikkers, Frederick G., Johnson, Romaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Triological Society Best Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084367/
https://www.ncbi.nlm.nih.gov/pubmed/35543118
http://dx.doi.org/10.1002/lary.30180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084367/
https://www.ncbi.nlm.nih.gov/pubmed/35543118
http://dx.doi.org/10.1002/lary.30180

Ejemplares similares